Relmada Therapeutics

+$0.43 (+1.59%) As of 2:32 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.

About RLMD

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. It focuses on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist, which is a New Chemical Entity (NCE) that potentially addresses areas of high unmet medical need in the treatment of central nervous system (CNS) diseases and other disorders.

CEO

Sergio Traversa

Employees

Headquarters

New York, New York

Founded

2012

RLMD Key Statistics

Market Cap

481.21M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

129.71K

High Today

$27.77

Low Today

$27.18

Open Price

$27.18

Volume

31.41K

52 Week High

$40.47

52 Week Low

$20.60

Analyst Ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

RLMD Earnings

-$1.56

-$1.04

-$0.52

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Nov 11, After Hours